FDA 483 - Unknown Company - November 15, 2001

This document is an excerpt from an FDA Form 483, issued by the Department of Health and Human Services, Food and Drug Administration, following an inspection conducted on November 15, 2001. An FDA Form 483 is issued to a company’s management at the conclusion of an inspection when an investigator has observed conditions or practices that, in their judgment, may constitute violations of the Federal Food, Drug, and Cosmetic (FD&C) Act and related Acts. Based on the limited information provided, specific details regarding the company name, the nature of the main violations or issues observed, and the specific regulatory framework sections implicated are not available. Typically, these observations would detail findings related to manufacturing processes, quality control, facility conditions, or documentation practices that deviate from Good Manufacturing Practices (GMP) or other relevant regulations. While the document indicates an FEI Number (FDA Establishment Identifier), the actual identifier is redacted or not provided. Furthermore, the specific actions required to address the observations are not outlined in this snippet. In a complete FDA 483, the observations would be clearly itemized, requiring the inspected entity to investigate the issues, implement corrective and preventive actions, and provide a written response to the FDA detailing how the observations will be addressed to ensure compliance with federal regulations. The omission of these critical details in the provided text prevents a comprehensive analysis of the inspection findings and the company's compliance status.